DIVA Laboratories, Ltd. (TPEX:4153)

DIVA Laboratories Revenue

DIVA Laboratories had revenue of 222.90M TWD in the quarter ending March 31, 2026, with 7.62% growth. This brings the company's revenue in the last twelve months to 884.63M, up 4.44% year-over-year. In the year 2025, DIVA Laboratories had annual revenue of 868.84M with 0.76% growth.

• Revenue (ttm): 884.63M
• Revenue Growth: +4.44%
• P/S Ratio: 2.07
• Revenue / Employee: 5.74M
• Employees: 154
• Market Cap: 1.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	868.84M	6.52M	0.76%
Dec 31, 2024	862.32M	-31.52M	-3.53%
Dec 31, 2023	893.84M	-55.36M	-5.83%
Dec 31, 2022	949.20M	236.97M	33.27%
Dec 31, 2021	712.23M	-24.69M	-3.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error